Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

S2E32: Geriatric Psychopharmacology for PMHNPs: Safe Prescribing for Older Adults

23 min · 8 de jun de 2026
Portada del episodio S2E32: Geriatric Psychopharmacology for PMHNPs: Safe Prescribing for Older Adults

Descripción

In this deep-dive episode, we unpack Geriatric Psychopharmacology for PMHNPs: Safe Prescribing for Older Adults. Older adults are the fastest-growing population in psychiatric practice, and standard adult prescribing approaches can be dangerous in this group. This guide covers age-related pharmacokinetic changes, Beers Criteria application, deprescribing strategies, and evidence-based approaches to depression, anxiety, insomnia, and agitation in older adults. Read the full post: https://psychnpfellowship.com/geriatric-psychopharmacology-pmhnp-safe-prescribing-older-adults/

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

105 episodios

episode S2E57: PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45 artwork

S2E57: PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45

In this deep-dive episode, we unpack PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Insurance credentialing for a new PMHNP usually takes 90 to 150 days per payer. A 16-week gap between diploma and first insurance check can cost $60,000 in delayed revenue. Five pre-application moves compress most timelines to 45-60 days. Supervision-required states (TX, FL, PA, others) add a separate approval step. Plan for it. California’s AB 890 independent-practice phase-in is live in 2026. The credentialing packet changed with it. The biggest revenue leak is not the wait. It’s the re-attestation lapse at day 121. In This Post Why the 120-Day Timeline Exists The Real Cost of Waiting The Five Pre-Application Moves What Read the full post: https://psychnpfellowship.com/pmhnp-insurance-credentialing-timeline-2026/

13 de jul de 202622 min
episode S2E56: Handling Patient Pushback: A New PMHNP’s Confidence Playbook artwork

S2E56: Handling Patient Pushback: A New PMHNP’s Confidence Playbook

In this deep-dive episode, we unpack Handling Patient Pushback: A New PMHNP’s Confidence Playbook. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR. New PMHNPs rarely fail because of pharmacology gaps. They stumble when a patient pushes back and the clinician freezes, over-explains, or caves. This playbook shows a 3-step script — Acknowledge, Anchor, Advance — that holds clinical ground, protects the therapeutic alliance, and builds confidence in 60 to 90 days. Includes what most new grads get wrong, a named Fellowship drill, and a 6-question FAQ. In this article Why Patient Pushback Breaks New PMHNPs The Triple-A Script: Acknowledge, Anchor, Advance What Most People Get Wrong About Patient Pushback Four Pushback Scenarios and How to Handle Each The Weekly Debrief Dr Read the full post: https://psychnpfellowship.com/handling-patient-pushback-new-pmhnp-confidence-playbook/

10 de jul de 202624 min
episode S2E55: Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know artwork

S2E55: Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know

In this deep-dive episode, we unpack Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Pramipexole (Mirapex), a dopamine D3 receptor agonist FDA-approved for Parkinson’s disease, showed strong results in the PAX-D trial published in The Lancet Psychiatry for treatment-resistant unipolar depression. At a target dose of 2.5 mg/day added to existing antidepressants, patients saw significant symptom reduction by week 12, with benefits lasting through 48 weeks. PMHNPs should know the titration protocol, watch for impulse control disorders and nausea, and understand where this fits in the treatment algorithm after two or more failed antidepressant trials. In This Article Why Dopamine Matters in Treatment-Resistan Read the full post: https://psychnpfellowship.com/pramipexole-treatment-resistant-depression-pmhnp-guide/

9 de jul de 202622 min
episode S2E54: PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026 artwork

S2E54: PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026

In this deep-dive episode, we unpack PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR The PMHNP-BC opens doors, but subspecialty certifications open better ones. In 2026, four advanced credentials — CARN-AP (addiction), PMH-C (perinatal), PMHS (pediatric), and CPRP (psychiatric rehabilitation) — are creating salary bumps, sharper clinical confidence, and access to specialized roles that generalist PMHNPs can’t touch. This post breaks down each certification, what it takes to earn them, and why early-career PMHNPs should start thinking about specialization now rather than later. In This Post Why Subspecialization Matters Now CARN-AP: Addiction Nursing for Advanced Practice PMH-C: Perinatal Mental Health Cer Read the full post: https://psychnpfellowship.com/pmhnp-subspecialty-certifications-2026/

8 de jul de 202622 min
episode S2E53: MHPAEA Enforcement 2026: What PMHNPs Need to Know About Mental Health Parity artwork

S2E53: MHPAEA Enforcement 2026: What PMHNPs Need to Know About Mental Health Parity

In this deep-dive episode, we unpack MHPAEA Enforcement 2026: What PMHNPs Need to Know About Mental Health Parity. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR The federal government is cracking down on mental health parity violations in 2026, and the results are staggering: every single health plan analysis reviewed by the Department of Labor failed initial compliance. For PMHNPs, this means new leverage in rate negotiations, stronger grounds for prior authorization appeals, and a shifting insurance environment that could finally close the gap between psychiatric and medical reimbursement. Here’s what you need to know and how to use it. In This Article What Is MHPAEA and Why 2026 Matters The DOL’s 210-Plan Audit: Zero Compliance Prior Authorization Under the Microscope What Thi Read the full post: https://psychnpfellowship.com/mhpaea-enforcement-2026-pmhnp-mental-health-parity/

7 de jul de 202624 min